SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " CAS " 14,374 found 🔀 AI-powered Shuffle
Santa Ana Star Casino Hotel launches app, unveils July entertainment lineup
Santa Ana Star Casino Hotel offers comedy, entertainment, perks, and more. In July, the casino has a lineup of comedians and other entertainment. July Entertainment Lineup June 26, 27 – Carme…
PAHO mobilizes emergency health response following earthquakes in Venezuela
Caracas, Venezuela/Washington, D.C., 25 June 2026 (PAHO) – The Pan American Health Organization (PAHO) has activated its emergency response mechanisms to support the health response in Venezuela following two magnitude 7.5 earthquakes that struck the country on June 24.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
PANAM SPORTS AND THE CANADIAN COACHES ASSOCIATION LAUNCH A CERTIFICATION PROGRAM FOR COACHES IN THE AMERICAS
With the goal of training and supporting the development of coaches on […]
New science on algae die-offs is too late for the Reflecting Pool
Iron and hydrogen peroxide trigger cell death via ferroptosis, which cascades killer molecules through the population, causing mass die-offs of algae.
Following IAM Union Advocacy, Kansas PERB Orders Count of Timely Cast Ballots in KU Health System Pharmacy Technician Union Election
KANSAS CITY, Kan. — Following weeks of advocacy from the IAM Union, Pharmacy Technicians, elected officials and community supporters, the Kansas Public Employee Relations Board (PERB) has ruled that 37 previously uncounted ballots will be included in the final tally of the recent union representation election involving Pharmacy Technicians at the University of Kansas (KU)
Earthquakes Have Often Shaken Latin American Politics
How governments respond to natural disasters can shape their political trajectories, an expert writes.
This week in science: Exoplanetary salt clouds, ancient families and laughter's origin
Hosts from NPR's science podcast Short Wave talk about an exoplanet with pink, salty clouds, the surprising social structure of ancient human relatives and the origins of laughter.
Participating in heavy-contact youth sports, dropping out of sports linked to acts of violence
Contrary to popular belief, simply playing organized youth sports does not reduce the likelihood of committing violence in one’s lifetime, and in some cases, may increase it, according to a new study.The study, published online recently in the Sociology of Sport Journal, found that while most survey respondents — including those who played y...
Cast a Line for Free Across New York June 27–28
New Yorkers will be able to fish for free on June 27 and June 28.
Platner, Collins’ campaign spar over federal contracts
Platner released a multi-point plan he calls “a corruption crackdown,” which covers issues such as big money in politics, lobbying activities by former members of Congress, and making it more difficult for presidents to cash in on their position while in office.
South Dakota mayoral candidates separated by just two votes in shockingly close race, recount expected
The Sioux Falls mayoral runoff contest shockingly resulted in just a two-vote margin separating the candidates out of more than 36,000 ballots cast.
Misericordia University Students Earn Top Honors at Pennsylvania Academy of Science's 101st Annual Meeting
Misericordia University students earned multiple prestigious awards while showcasing undergraduate research at the 101st Annual Meeting of the Pennsylvania Academy of Science (PAS), held this year on the Misericordia University campus—the first time the statewide scientific organization has hosted its annual conference at the university.
Sean Hannity Explains Puffy Face in Health Update Amid Viewer Concern
Sean Hannity gave a health update after viewers expressed concern about his puffy face and raspy voice in recent Fox News telecasts.
How Caesars’ Expanded Tribal iGaming and Community Partnership Could Shape Caesars Entertainment (CZR) Investors’ Outlook
In June 2026, Caesars Entertainment Inc. announced that it had expanded its partnership with three Wabanaki Nations in Maine to cover online casino gaming, aiming to launch Caesars Palace Online Casino, Caesars Sportsbook & Casino and Horseshoe Online Casino in 2026, subject to regulatory approval and integrated with Caesars Rewards and a universal digital wallet. A distinctive element of this agreement is Caesars’ commitment to employ and train tribal members while providing financial...
From the Beginning, Politics Triggered Broadcasting
Media scholars argued that politics, not technology, shaped American broadcasting from 1927 on, repeatedly shielding incumbents from competition.
Commitment: Texas lands 2027 three-star IOL Lucas Rhoa
The Texas Longhorns continue a great week of recruiting by landing 2027 three-star interior offensive lineman Lucas Rhoa.
Strip casino project proposing new 2,000-seat live entertainment venue
Hard Rock is doubling down on its commitment to live entertainment at its $4 billion Strip resort project.
MIT in the media: Exploring how curiosity-driven science is an essential ingredient in America’s success
“Scientific American” showcases the history and future of America’s scientific engine, highlighting promising young scientists and icons at MIT and beyond.
Comcast's Sky Reaches Terms to Acquire ITV's Media & Entertainment Unit for $2 Billion
The deal, which includes ITV's linear channels and ITVX streaming platform, could be announced in the next two weeks, according to Reuters
Comcast’s Sky Reaches Terms to Acquire ITV’s Media & Entertainment Unit for $2 Billion
The deal, which includes ITV's linear channels and ITVX streaming platform, could be announced in the next two weeks, according to Reuters
Entertainment this week: Paul Thorn, Hike for Hope and more
Friday, June 26 Annual Ian Casey Classic – Tahoe Donner Golf Course. Our most popular event of the year, a full field of 130+ golfers will team up in foursomes and hit the links to...
Comcast's Sky to Buy ITV's Media and Entertainment Unit for $2.1 Billion
Comcast-owned Sky Group has reportedly agreed to acquire the media and entertainment business unit of U.K.-based ITV for $2.1 billion. The deal is expected to be officially announced in two weeks. Satellite operator Sky will absorb ITV’s broadcast network, linear free-to-air channels, and the ITVX subscription streaming service with 900,000 paid subscribers and 16.4 million … Continue reading "Comcast’s Sky to Buy ITV’s Media and Entertainment Unit for $2.1 Billion"
Supreme Court protects pesticides from some health claims in key Roundup case
The Supreme Court on Thursday restricted Americans’ ability to sue pesticide makers over alleged health harms stemming from their products. In a 7-2 ruling, the court held that some claims that pes…
Semi-communal 'compound houses' in Ghana affect how people participate in political activity
Could the precise architectural form of your residence influence how much you participate in politics? A new study by MIT scholars finds this to be exactly the case—at least in Accra, Ghana, where many ...
Make/Films opens new Lancaster city studio in Stadium District
Make/Films — the studio that brought a story about a Garden Spot teacher to movie theater screens nationwide — recently tripled its space with a new studio.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
Everything Announced At The 2026 Capcom Spotlight
Here's a quick recap of the 30-minute broadcast.
Moody Center announces exhibition exploring math, science and tech rooted in Indigenous knowledge systems
Through a framing of North, Central and South America as interconnected regions, “Radiant Geometries: Vectors of Knowledge from the Indigenous Americas” brings together contemporary Indigenous and Latin American artists whose practices illuminate knowledge as a living technology, through which the mathematical, metaphysical and artistic realms converge.
Ebola response highlights value of African science
With African scientists leading the way in the latest Ebola response, Catherine Kyobutungi makes the case for long-term investment.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Mamdani and Hochul announce cash infusion for New York City Abortion Access Hub expansion
New York City and the Empire State are infusing hundreds of thousands of dollars into New York City Abortion Access Hub to expand its referral network
Kustom Entertainment Announces $5.5 Million Divestiture of Legacy Video Solutions Division to Cycurion, Advancing Live Entertainment Focus
Kustom Entertainment announces divestiture of video solutions division to Cycurion, enhancing focus on live events and ticketing.Quiver AI SummaryKustom Entertainment, Inc. announced a binding agreement to sell its legacy video solutions division to Cycurion, Inc., in a deal worth up to $5.5 million, including $1.25 million in cash and a $4.25 million promissory note. The transaction, expected to close in July 2026, will provide Kustom with finan
TikTok and YouTube are reinventing sports viewership. Broadcasters are taking note
Leagues, teams and media networks are increasingly meeting younger fans on social media as platforms like TikTok, Roblox and YouTube capture most of their time.
TikTok and YouTube are reinventing how young fans watch sports
Sports TV ratings and live rights fees are soaring, but professional leagues and broadcasters are facing a new battleground for young fans. Social platforms like TikTok and YouTube are claiming an increasing share of viewing hours among Generations Z and Alpha. Sports clips, highlights and creator content can introduce younger fans to professional sport, but how do the major players cash in?
Senate Republicans reject war powers resolution after Trump-Cassidy clash
The late-night vote came hours after a fractious meeting that included a shouting match with President Donald Trump over some senators’ opposition to the conflict.
Germany's Merck to buy Bio-Techne for $73 per share
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
Former Sparrow hospitals see improved finances 3 years after UM merger
The former Sparrow Health System was bleeding cash when it was swept up by the University of Michigan Health network three years ago. That's changed.
What we know about Trump’s Great American State Fair
The Trump administration’s 16-day-long Great American State Fair has begun, offering visitors to the National Mall in Washington, DC, the chance to visit pavilions showcasing every US state and territory.
Folarin Balogun and USMNT Transfer Updates
Hosts Tamerra Griffin and James McNicholas break down a massive six-match World Cup slate as group stages reach their climax. Soccer insider David Ornstein joins the show to discuss the escalating transfer market buzz surrounding USMNT star Folarin Balogun and Tottenham’s Lucas Bergvall. Plus, the team highlights The Athletic’s interactive World Cup Tracker with Jay Harris to map out the complicated qualification pathways for Group A, B, and C. Can the USMNT line up a favorable Round of 32 matchup? Senior Editor Hannah Vanbiber also dives into the debate surrounding Jeremy Doku’s...
Chemours looks to settle federal PFAS case for $450 million. NC wasn’t at the table.
North Carolina is home to the only Chemours facility GenX facility, yet the state may have no claim to any of the PFAS penalty funds.
BBC signs new Wimbledon deal until 2033
BBC Sport will continue to broadcast Wimbledon until 2033 after signing a new deal with the All England Club.
Politics in the Park: GOP gubernatorial candidates share visions for Wyoming governor
CASPER, Wyo. — Three Republican gubernatorial candidates shared their views on a myriad of topics spanning taxation, energy production, resource rights
Politics in the Park: GOP gubernatorial candidates share visions for Wyoming governor
CASPER, Wyo. — Three Republican gubernatorial candidates shared their views on a myriad of topics spanning taxation, energy production, resource rights
When WA's behavioral health system failed her son, Blaine mom declared herself an unfit parent
A mother's experience with 'cycle of insufficient care' for troubled children in Washington
Hollywood production house closes, citing entertainment industry struggles
'Grease' star Didi Conn recalls the cast 'being horny' during production of the classic musical
Didi Conn is looking back at her time portraying Frenchie Facciano in the 1978 musical 'Grease,' a 'crazy' production that consisted of 'having fun and being horny or whatever.'
Louisville doctor, nurse and nonprofit founder charged in federal health care fraud crackdown
Federal prosecutors in the Western District of Kentucky announced charges in four separate cases involving alleged schemes to defraud Medicare and Medicaid, misuse medical credentials and controlled substances, and submit
MentalHood Cultural Initiative improving men's mental health
The MentalHood Cultural Initiative is improving men's mental health, hosting the masculine male brunch and podcast premiere on Saturday in Chicago.
NATO’s Leader Makes His Case to Trump for Preserving the Alliance
Using charts, Secretary General Mark Rutte appeared to defuse the president’s anger by showing that European countries were “equalizing” defense spending with the U.S.
Measles exposure reported at Hollywood Burbank Airport, county health officials say
Los Angeles County health officials announced Wednesday they are investigating a confirmed case of measles involving a traveler who may have exposed people to the highly contagious disease at Hollywood Burbank Airport and elsewhere in the county.
Micron and Qualcomm forecasts ignite $400 billion AI chip stock rally
Shares of chipmakers surged late on Wednesday, adding over $400 billion in market value after strong forecasts from Micron Technology and Qualcomm breathed fresh life into Wall Street's recently waning AI stock rally.
Why Millie Bobby Brown apologized to 'Stranger Things' cast after finale
Millie Bobby Brown doesn't need telepathy to tell the world how she feels about the end of "Stranger Things."
World Cup crowds bring some boom, some bust for Seattle businesses
Ahead of Wednesday's World Cup match in Seattle, a clear pattern had emerged: Bars, cafés, and restaurants are surging with game-day energy, while many retail shops and businesses outside the immediate fan orbit are struggling to cash in.
Family mourns man found dead in south Bexar County business as BCSO searches for shooter
Bexar County sheriff’s investigators say they have little information on a murder case that has left a big hole in the hearts of one family.
Pa. measles cases jump, spread to Northumberland County
An unprecedented measles outbreak in the state has spread to an additional county, the Pennsylvania Department of Health announced Wednesday. Health officials...
Milwaukee County judge weighs in on rising mental health felony cases
Investigative reporting found that mental competency evaluations in felony cases have roughly doubled since 2013, straining resources for the state criminal justice system.
Sports/Rec calendar: June 26–July 5, 2026
Upcoming recreation opportunities and college and prep sports
‘He named names’: Trump’s Senate meeting explodes into shouting match over Iran
Trump's meeting with Senate Republicans devolved into a shouting match over Iran war powers, with Sen. Bill Cassidy confronting the president directly.
Casey's CEO on fuel margins, expansion, food business and more
Casey’s General Stores chair and CEO Darren Rebelez joins CNBC's "Closing Bell Overtime" to discuss the company's food and fuel business, its outlook and more.
Star Fox Nintendo Switch 2 voice actors revealed, including Fox, Falco, Peppy, Slippy, and more
The full Star Fox Nintendo Switch 2 cast has now been revealed, and here are the new voices for Fox, Falco, Peppy, Slippy, and more.
'ANTM' cycle 25 might cast 'an AI contestant,' Tyra Banks rep says (exclusive)
'America's Next Top Model' cycle 25 might include 'an AI contestant,' a representative for Tyra Banks exclusively tells EW after Banks' ice cream brand removed AI-generated models from an ad.
Micron forecasts quarterly revenue above estimates
Micron Technology forecast quarterly revenue above Wall Street estimates on Wednesday, signaling that insatiable demand for AI-related infrastructure will continue to drive strong demand for its memory chips.
Steam Machine Sells Out in Japan Despite Woeful Pricing
As was the case with the Steam Deck, Valve is selling the Steam Machine via Komodo Station, an Asian reseller that serves much of South-East Asia, and as a result, it skips the reservation and lottery system that is currently in place on Valve's own Steam Store. While this doesn't combat issues like...
Country powerhouse Sara Evans dives into Tulsa Sept. 25
Hard Rock Hotel & Casino Tulsa will welcome multiplatinum country music powerhouse Sara Evans at 8 p.m. Friday, Sept. 25, at Hard Rock Live inside the casino.
Las Vegas woman accused of running illegal multi-million-dollar healthcare scheme in Pearland, prosecutors say
Marizel Yukee is accused of providing medically unnecessary allografts to patients while receiving kickbacks, according to the U.S. Attorney’s Office. Her case is one prosecutors are citing as part of a national crackdown on health care fraud.
Usher says tour with Chris Brown is about more than 2 stars. He makes the case for R&B in stadiums
Usher is launching a stadium tour with Chris Brown and says Brown's legal troubles never influenced his decision.
Federal judge bars Trump from implementing proof of citizenship requirement to vote
The ruling by U.S. District Court Judge Denise Casper in Boston effectively converts a preliminary injunction she issued a year ago, in which she temporarily blocked many of Trump’s efforts to overhaul elections, into a permanent ban.
Aon Center owner seeks another loan extension as tower’s value plummets
The debt trouble at Chicago’s second-tallest office tower is one of the largest cases of imminent distress downtown amid weakened demand for workspace.
What does CBS Sports think is the best case scenario for the Vikings?
The Vikings season could go one of two ways, what does CBS Sports think is the good way?
Bringing the Lab into the Classroom with NYC’s Youngest Scientists
The Scientist-in-Residence Student Showcase is a culminating celebration of science education.
Sky Sports F1 broadcaster confirms exit
Rachel Brookes has left Sky Sports after 17 years at the company
Trio behind string of business burglaries caught after chase through Tucker
Police said the suspects threw cash register tills and other stolen items from the vehicle.
Leslie Jones says being typecast as 'angry' on 'SNL' was 'frustrating'
Former "Saturday Night Live" star Leslie Jones is looking back on the "frustrating" feeling of being typecast as a certain kind of "angry" character on the show.
USPS tells Congress it needs cash rescue amid broken business model
Postmaster General David Steiner told a Senate committee the agency has amassed nearly $31 billion in cumulative defaults and could run out of cash by year's end
What Are Colts' Best and Worst-Case Scenarios in 2026?
It's apparent that the Indianapolis Colts' success in 2026 lies heavily on quarterback Daniel Jones' shoulders.
HHS Successfully Concludes Hantavirus Response Effort; Monitoring Ends with No Positive U.S. Case
HHS announced the successful conclusion of the federal public health response to the Hantavirus exposure event associated with the M/V Hondius cruise ship.
Butler County health officials confirm bat tests positive for rabies, marking 4th case in past month
Butler County health officials say a bat has tested positive for rabies in West Chester, marking at least the fourth positive case in Butler County over the last two months.
Google’s New $100 Speaker Makes a Weak Case for Gemini in the Home
The Google Home Speaker is the first new device of its kind to come from Alphabet Inc. in six years. In that time, Google has reshaped itself as an industry leader in artificial intelligence, with its Gemini platform now ubiquitous across consumer hardware like smartphones and web services like Search, Workspace and YouTube.
CC Biz Buzz: A busy business is not always a healthy one
Columbia College Business faculty member Gina Singleton writes about lessons of cash versus revenue.
Day Two of Competition Highlights Athletes Across Multiple Sports
The second day of competition at the 2026 Special Olympics USA Games was cut short due to inclement weather, but not before some memorable moments. Before outdoor events were halted, athletes showcased speed on the track, excitement and enthusiasm at gymnastics, and pride on the football and soccer fields. Even as an athletics athlete from Special Olympics Southern California lost his shoe, he managed to win the race.
As Ebola cases surge above 1,000, experts say outbreak could be worst ever
Insufficient contact-tracing and the refusal of many residents to avoid contact with the bodies of loved ones killed by the Ebola virus are accelerating the epidemic.
The hidden stakes of the birthright citizenship case: healthcare for babies
The birthright citizenship case in front of the US Supreme Court is about much more than just citizenship. It’s also about an issue that was little discussed in court arguments: babies’ immediate access to safety net programs and medical tests that need to be done within the first couple days of life.
Behind the scenes of a successful entertainment career with Jenny Austin ’12
From interviews with big-name celebrities like Will Ferrell to assisting with casting for hit television shows like “The Summer I Turned Pretty,” Jenny Austin ’12 is living out her dreams....
Financing the Future: Leaders Make the Investment Case for Women's, Children's and Adolescents' Health
With development assistance declining and health systems under growing strain, leaders at Africa Health ExCon called for a shift from fragmented financing to integrated, sustainable investment in women’s, children’s and adolescents’ health. Discussions highlighted domestic financing, private sector engagement, service integration and climate-resilient health systems as pathways to greater impact.
France Identifies First Case of Ebola
The patient is a doctor who had traveled to the Democratic Republic of Congo, the health ministry said. Workers are racing to trace those who may have had contact.
The 4 GOP senators who broke ranks and voted to block Trump from resuming Iran war
The president seethed at Susan Collins, Bill Cassidy, Lisa Murkowski and Rand Paul after the war powers resolution passed, saying: "I will get it done, one way or the other."
PENN Entertainment Celebrates Grand Opening of Hollywood Casino and Hotel Aurora
PENN Entertainment, Inc. (Nasdaq: PENN) (“PENN” or the “Company”) today celebrates the grand opening of Hollywood Casino and Hotel Aurora, the all-new, $360 ...
PENN Entertainment Celebrates Grand Opening of Hollywood Casino and Hotel Aurora
WYOMISSING, Pa. & AURORA, Ill., June 24, 2026--PENN Entertainment, Inc. (Nasdaq: PENN) ("PENN" or the "Company") today celebrates the grand opening of Hollywood Casino and Hotel Aurora, the all-new, $360 million state-of-the-art casino and hotel. PENN’s latest land-based property replaces the former riverboat property that operated on the Illinois shores of the Fox River since 1993.
France confirms first Ebola case in doctor returning from DR Congo
The patient is in isolation, following strict biosafety protocols to prevent risk of spread in France.
Movies and TV shows casting across the US
Backstage compiled a list of movies and TV shows casting across the US.
Podcasts are Changing the Doctor-Patient Dynamic. Is That a Good Thing?
The dynamic in the exam room is changing as more people show up ready to talk about what they’ve heard on podcasts.
Death Row Disability Cases Are Questions of Morality, Not Science
Doctors’ input on how to weigh cognitive disability in death penalty cases can be helpful, but characterizing such judgments as science misrepresents medicine and psychology, says Dr. M. Gregg Bloche of Georgetown Law.
Braves blow another one in 7-6 loss to Padres
A wild night at Petco Park was capped off by a walk-off single by way of Manny Machado as the Braves fell to the Padres, 7-6, in 10 innings. This is a bad baseball team at the moment. The second inning was a doozy for both sides. The Braves loaded the bases and cashed in […]
Chicago health officials warn of potential measles exposure at O’Hare airport
Chicago health officials are investigating a case of measles in a traveler who arrived at O’Hare International Airport on June 17.
New York Yankees @ Detroit Tigers: Carlos Rodón vs. Casey Mize
Rodón looks to end this brief three-game skid and set up a Wednesday rubber game.
AMC Entertainment Holdings (AMC) Is Down 16.5% After Dilutive Debt-Reduction Equity Raise - Has The Bull Case Changed?
Earlier today, AMC Entertainment Holdings announced a registered direct follow-on equity offering of 95,250,000 common shares at about US$2.10 each, aiming to raise roughly US$200.03 million primarily to redeem 6.125% Senior Subordinated Notes due 2027 and for general corporate purposes. This latest capital raise follows AMC’s roughly US$150 million at-the-market equity offering completed in early June, underlining how ongoing balance sheet repair is coming at the cost of further dilution...